Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details)

v3.22.2.2
Stock-Based Compensation (Details)
9 Months Ended
Oct. 01, 2022
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Nonvested Beginning balance Number of shares | shares 237,000
Granted, Number of shares | shares 102,000
Vested, Number of shares | shares (109,000)
Forfeited, Number of shares | shares (14,000)
Nonvested Ending balance Number of shares | shares 216,000 [1]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Nonvested Beginning balance, Weighted average grant-date fair value | $ / shares $ 45.58
Granted, Weighted average grant-date fair value | $ / shares 92.41
Vested, Weighted average grant-date fair value | $ / shares 43.79
Forfeited, Weighted average grant-date fair value | $ / shares 66.84
Nonvested Ending balance, Weighted average grant-date fair value | $ / shares $ 67.26 [1]
[1] (1) Includes 106,221 nonvested performance-based RSUs.